LHIX
CETRORELIX ACETATE
LHIX
250 mcg Lyophilized Powder for Injection (S.C.)
Anti-gonadotropin-releasing Hormones
Formulation
Each vial contains:
Cetrorelix acetate equivalent to
| Cetrorelix | 250 mcg |
| Excipients | q.s. |
After reconstitution with the Diluent Sterile Water for Injection, each mL of the solution contains 0.25 mg cetrorelix.
Indications:
Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.
In clinical trials Cetrorelix was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicle-stimulating hormone (FSH) suggested similar efficacy.
In clinical trials Cetrorelix was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicle-stimulating hormone (FSH) suggested similar efficacy.
Dosage and Administration:
Cetrorelix should only be prescribed by a specialist experienced in this field.
Storage:
Store at temperatures not exceeding 30O C.
Availability:
Box of 30’s and 60’s film-coated tablet.
Medical Disclaimer:
Please consult your physician for personalized medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition or treatment before undertaking a new healthcare regimen. This product brief is not an advertisement and is not intended to be a substitute for a professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it. If symptoms persist, consult your physician.
